[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75842]], camposKey:2072-6694 2023-03-01 Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66964]], camposKey:0007-1048 2020-05-01 Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients718730, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68829]], camposKey:0939-5555 2018-03-01 Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study475484, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47750]], camposKey:0145-2126 2009-06-01 Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44262]], camposKey:0210-6523 2008-01-01 Tratamiento con anticoagulantes orales: dilemas y soluciones7184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47753]], camposKey:0929-5305 2006-01-01 Oral anticoagulant treatment: Risk factors involved in 500 intracranial hemorrhages113120, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47755]], camposKey:1130-0108 2005-09-01 Primary biliary cirrhosis, "sicca" syndrome and autoimmune hemolytic anemia [5] Cirrosis biliar primaria, síndrome "sicca" y anemia hemolítica autoinmune678679, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38347]], camposKey:0009-7330 2004-01-01 Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction742748, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44263]], camposKey:0210-6523 2004-01-01 Trombosis venosa en pacientes con factor V Leiden4959, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47758]], camposKey:1466-4860 2003-08-11 Emphysematous gastritis and severe aplastic anemia8284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47759]], camposKey:0014-2565 2003-05-01 Treatment of coagulopathy in severe sepsis Tratamiento de la coagulopatía en la sepsis severa240241, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=44261]], camposKey:0014-2565 2003-01-01 Tratamiento de la coagulopatía en la sepsis severa240241][][][][][][][][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f95ad, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9158, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9811, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8f27, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f887c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f82c2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8e54, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f84dd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9109, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f910a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9669, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f90ab][][][][][][][][][][][][][][][]